-
Posted by
Two Blokes Jul 8 -
Filed in
Stock
-
7 views
I maintain a hold rating on PPH due to attractive valuation but weak technical momentum and underperformance versus the S&P 500. Eli Lilly and Johnson & Johnson, PPH's largest holdings, are facing unique challenges, impacting the ETF's overall performance and outlook. Despite a low P/E ratio and solid dividend yield, PPH's concentrated portfolio and poor price action warrant caution for now.
